Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation

Published:2019-11 Issue:11 Volume:25 Page:2281-2286
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Suárez-Lledó María,Marcos Maria Ángeles,Cuatrecasas Miriam^ORCID,Bombi Josep Antoni,Fernández-Avilés Francesc,Magnano Laura,Martínez-Cibrián Núria,Llobet Noemi,Rosiñol Laura,Gutiérrez-García Gonzalo,Jorge Sofía,Martínez Carmen,Rovira Montserrat,Urbano-Ispizua Álvaro

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Diagnosis and treatment of cytomegalovirus 2013;Einsele;Curr Opin Hematol,2014

2. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

3. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation;Ljungman;Clin Infect Dis,2014

4. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT;Ljungman;Bone Marrow Transplant,2004

5. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT;Schmidt-Hieber;Blood,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus infection in gastroenterology;Terapevticheskii arkhiv;2024-09-14

2. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

3. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

4. Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum;Clinical Infectious Diseases;2024-07-23

5. Clinical characteristics and outcomes of immunocompromised critically ill patients with cytomegalovirus end-organ disease: a multicenter retrospective cohort study;Critical Care;2024-07-16